Advertisement
Advertisement
ORKA
Oruka Therapeutics Inc.
21.50
USD-0.95
-4.23%
Dec 18, 14:37 UTC -5
Open
Oruka Therapeutics Inc. Profile
About
Info & Links
CEO
Michael R. Bristow
Headquarters
WESTMINSTER, CO 80021, UNITED STATES
Industry
Sector
Website
Auditor
KPMG LLP
Share holders
13
Employees
5
Oruka Therapeutics Inc. Statistics
Valuation Measures
Market Capitalization2
752.50M
Enterprise Value
341.63M
Enterprise Value/EBITDA(ttm)
-9.33
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
--
Price to Book(mrq)
2.26
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
0.00%
Operating Margin(ttm)
--
Profit Margin(ttm)
0.00%
Return on Equity(ttm)
-24.96%
Return on Invested Capital(ttm)
-24.13%
Return on Assets(ttm)
-21.22%
Income Statement
Revenue(ttm)
0.00
Revenue Per Share(ttm)
0.00
Gross Profit(ttm)
0.00
EBITDA(ttm)3
-36.61M
Net Income Available to Common(ttm)
-34.40M
Diluted EPS(ttm)
-6.26
Share Statistics
Beta (5Y Monthly)
0.78
52-Week Change
81.05%
S&P 500 52-Week Change
26.60%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
35.00M
Dividend Yield
0.00%
Float4
27.07M
% Held by Insiders
22.67%
% Held by Institutions
56.44%
Balance Sheet
Total Cash(mrq)
410.88M
Total Cash Per Share(mrq)
11.74
Total Debt(mrq)
0.00
Total Debt/Equity(mrq)
0.00%
Current Ratio(mrq)
22.89%
Quick Ratio(mrq)
22.89%
Book Value Per Share(mrq)
11.29
Cash Flow
Operating Cash Flow Per Share(ytd)
-2.60
Free Cash Flow(ytd)
-39.19M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
- 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
- 2 Market Cap is calculated using total shares outstanding and the most recent share price.
- 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
- 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement